[{"Assets_0_Q2_USD":5488661000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":351100000.0,"NetIncomeLoss_1_Q2_USD":261898000.0,"NetIncomeLoss_2_Q2_USD":347099000.0,"StockholdersEquity_0_Q2_USD":2983434000.0,"EarningsPerShareBasic_1_Q2_USD":4.62,"EarningsPerShareBasic_2_Q2_USD":6.09,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":56707000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":56955000.0,"Ticker":"JAZZ","CIK":"1232524","name":"JAZZ PHARMACEUTICALS PLC","OfficialName":"Jazz Pharmaceuticals plc Common Stock (Ireland)","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"10281986580.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]